A Double-Blind Randomized Controlled Pilot Trial of N-Acetylcysteine in Veterans with PTSD and Substance Use Disorders

OBJECTIVE: The antioxidant N-Acetylcysteine (NAC) is being increasingly investigated as a therapeutic agent in the treatment of substance use disorders. Preclinical and clinical findings suggest that NAC normalizes extracellular glutamate by restoring the activity of glutamate transporters and antip...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Psychiatry
Autors principals: Back, Sudie E., McCauley, Jenna L., Korte, Kristina J., Gros, Daniel F., Leavitt, Virginia, Gray, Kevin M., Hamner, Mark B., DeSantis, Stacia M., Malcolm, Robert, Brady, Kathleen T., Kalivas, Peter W.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226873/
https://ncbi.nlm.nih.gov/pubmed/27736051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.15m10239
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars